← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2019Last known activity
Feb 1, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT04748796CollaboratorN/AFeb 1, 2021
- NCT04589546CollaboratorPhase 3Oct 31, 2020
- NCT03974139Overall official - principal investigatorPhase 2Sep 1, 2019
- NCT03974139CollaboratorPhase 2Sep 1, 2019
Details
- Last known activity
- Feb 1, 2021